Phase II trial of gemcitabine, carboplatin, and bevacizumab (Bev) in patients (pts) with advanced/metastatic urothelial carcinoma (UC).

被引：1
|
作者：
Balar, A. V.
Milowsky, M. I.
Apolo, A. B.
Ostrovnaya, I.
Iasonos, A.
Trout, A.
Regazzi, A. M.
Garcia-Grossman, I. R.
Gallagher, D. J.
Bajorin, D. F.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] NCI, Med Oncol Branch, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.4566
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4566
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I trial of gemcitabine/carboplatin(GC), followed by pemetrexed/gemcitabine (PG) in chemonaive patients (pts) with advanced NSCLC
    Steele, J.
    Patel, G.
    Klabatsa, A.
    Das, M.
    Kalidas, B.
    Nicoll, C.
    Wells, P.
    Fennell, D.
    Fennell, D. A.
    Rudd, R. M.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 529 - 529
  • [42] Phase II study of gemcitabine, paclitaxel, and carboplatin in patients with metastatic nasopharyngeal carcinoma (NPC)
    Tan, EH
    Leong, SS
    Wee, J
    Tay, MH
    Toh, CK
    Tan, SB
    Gob, F
    Tan, T
    Fong, KW
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, : 264 - 264
  • [43] NCCTG phase II trial of bevacizumab, gemcitabine, oxaliplatin in patients with metastatic pancreatic adenocarcinoma
    Kim, George P.
    Oberg, Ann L.
    Foster, Nathan R.
    Sargent, Daniel J.
    Jaslowski, Anthony
    Campbell, Deborah
    Hedrick, Eric
    Grothey, Axel F.
    Alberts, Steve R.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 310 - 310
  • [44] Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)
    Rosenberg, Jonathan E.
    Ballman, Karla A.
    Halabi, Susan
    Atherton, Pamela J.
    Mortazavi, Amir
    Sweeney, Christopher
    Stadler, Walter M.
    Teply, Benjamin A.
    Picus, Joel
    Tagawa, Scott T.
    Katragadda, Sreedhar
    Vaena, Daniel
    Misleh, Jamal
    Hoimes, Christopher
    Plimack, Elizabeth R.
    Flaig, Thomas W.
    Dreicer, Robert
    Bajorin, Dean
    Hahn, Olwen
    Small, Eric J.
    Morris, Michael J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (22) : 2486 - +
  • [45] Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinoma
    Urakami, Shinji
    Fujii, Yasuhisa
    Yamamoto, Shinya
    Yuasa, Takeshi
    Kitsukawa, Shinichi
    Sakura, Mizuaki
    Yano, Akihiro
    Saito, Kazutaka
    Masuda, Hitoshi
    Yonese, Junji
    Fukui, Iwao
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 35.e1 - 35.e7
  • [46] Final results of a phase II study of sunitinib in patients (pts) with relapsed or refractory urothelial carcinoma (UC)
    Gallagher, D. J.
    Milowsky, M. I.
    Gerst, S. R.
    Iasonos, A.
    Boyle, M. G.
    Trout, A.
    Riches, J.
    Bajorin, D. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Phase II trial of gemcitabine (G), carboplatin (C) and bexarotene (B) in patients (pts) with newly diagnosed, locally-advanced or metastatic non-small cell carcinoma of the lung (NSCLC).
    Estephan, FF
    Hasham-Jiwa, N
    Klementich, F
    Logrono, R
    Eltorky, M
    Bhutani, M
    Walser, E
    Zwischenberger, J
    Kessel, I
    Jones, DV
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 697S - 697S
  • [48] Randomized phase II/III trial comparing gemcitabine/carboplatin (GC) and methotrexate/carboplatin/vinblastine (M-CAVI) in patients (pts) with advanced urothelial cancer (UC) unfit for cisplatin-based chemotherapy (CHT): Phase III results of EORTC study 30986
    De Santis, M.
    Bellmunt, J.
    Mead, G.
    Kerst, J. M.
    Leahy, M. G.
    Daugaard, G.
    Gil, T.
    Maroto, J. P.
    Marreaud, S.
    Sylvester, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (18)
  • [49] A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer
    Kaufman, DS
    Carducci, MA
    Kuzel, TM
    Todd, MB
    Oh, WK
    Smith, MR
    Ye, ZS
    Nicol, SJ
    Stadle, WM
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2004, 22 (05) : 393 - 397
  • [50] Gemcitabine and oxaliplatin combination: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer.
    Font, A
    Esteban, E
    Carles, J
    Climent, MA
    Gonzalez-Larriba, JL
    Berrocal, A
    Bellmunt, J
    Garcia-Ribas, I
    Marfa, X
    Fabregat, X
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 392S - 392S
12345